Practice Areas & Industries: Duane Morris LLP

 




Faculty Practice Plans Return to Practice Areas & Industries

Group Profile Lawyers in this Group Offices Locations for this Group
 

Practice/Industry Group Overview

As the legal, regulatory and financial environments for healthcare providers continue to evolve, faculty practice plans (FPPs) face increasingly complex legal, strategic and operational challenges. FPPs are multimillion-dollar businesses and integral components of academic medical centers. They often seek separate legal representation from their academic medical center partners for assistance with critical operational issues such as organizational structure and governance, strategic and business planning, financial arrangements with affiliated academic medical centers and compensation plans. FPPs may also find that their interests diverge at times from their academic medical center partners, necessitating separate counsel.

Organizational Structure and Governance Design/Strategic and Business Planning

The structure and governance of each FPP is unique and influenced by a myriad of factors, including the relationship with the associated medical center and school. From comprehensive organizational restructuring to updating existing models, the attorneys of Duane Morris have assisted FPPs at all levels to achieve their goals and objectives. Our deep experience and familiarity with the distinctions between an FPP and a non-academic physician practice enables us to effectively improve both internal governance and the FPP's relationships with the senior leadership of its academic medical center. We also assist FPPs to structure mutually beneficial arrangements with the many non-academic providers such as community hospitals, clinics and pharmaceutical and medical device manufacturers who are eager to capitalize on the cutting-edge clinical services, as well and the teaching and research missions, of the FPP.

Financial Arrangements

The interests of the FFPs and their affiliated academic medical centers often diverge in negotiations of their complex financial arrangements. FFP physicians and staff are tasked with providing clinical services to patients, teaching students and participating in research. Funding arrangements must align with economic incentives and the center's mission while complying with a numerous legal requirements. Traditional or historical arrangements may no longer meet these needs or be compliant with current laws and regulations. Our considerable experience representing both FFPs and academic medical centers enables us to understand the business and legal issues from all perspectives and to design financial arrangements that serve the goals of both the FFP and the academic medical center. We also have extensive experience representing physician groups in managed care contract negotiations and can work with FFPs to ensure the best possible managed care contracts.

Compensation and Benefits Design

Individual physicians and their FPP often have differing compensation and benefits objectives. These are attributable to numerous factors, including a physician's position, age and remuneration level. We know that meeting competing objectives requires incentives to attract and retain the individuals within the FPP and a flexible compensation and benefits package. We counsel FPPs on all aspects of (1) compensation matters, including fixed and variable compensation, (2) retirement plan matters, including design of appropriate retirement benefit levels, and (3) welfare and fringe benefit programs (including group health). We prepare the relevant employment agreements and plans to document these arrangements.

Fraud and Abuse/STARK

FPPs typically involve relationships with hospitals and medical schools that include the transfer of funds to and from the plans. The referral of patients to the hospitals raises issues under the federal Stark and anti-kickback laws and similar state laws. These issues are addressed primarily by reference to the academic medical center exception to the Stark law, as well as more fact-specific analyses under the applicable anti-kickback statutes. Duane Morris attorneys are experienced in setting up and evaluating FPPs against the complex regulatory exceptions and safe harbors necessary for the prevention of violations and whistleblower lawsuits. Our attorneys know the sensitivities involved with these inherently competing interests and if necessary can facilitate a smooth and safe transition to a new or modified structure that properly aligns financial incentives with institutional goals. We also provide knowledgeable and vigorous defense in support of the FPP's relationships in the event of an investigation or lawsuit challenging its arrangement.

Tax Planning

Duane Morris attorneys are highly skilled in the identification, development and usage of tax-efficient structures designed to maximize our clients' after tax compensation, ensure taxes are not over-paid, and create solutions to tax-related issues that result from dealings with tax-exempt organizations. Our attorneys help protect favorable tax treatments, such as the use of the cash basis accounting method. Our attorneys are deeply familiar with the federal, state and local tax needs of FPPs.

Immigration

FPPs are often confronted with immigration issues relating to the hiring of foreign personnel. For example, it is critical for foreign personnel to have appropriate visas and that the employer files the applications. The lines that define the employee's and employer's respective responsibilities are often blurred. Non-immigrant visas include the J exchange visitor visa, the H-1B specialty occupation visa and the O extraordinary ability visa. A crucial component of the green card process includes labor certifications, employment-based petitions and applications for permanent residence or immigrant visas.

Immigration applications are scrutinized by Citizenship and Immigration Services, Department of Labor and Department of State. Duane Morris attorneys are experienced in all phases of the immigration process, and in particular with representing physician groups, hospitals, doctors, nurses, occupational and physical therapists, biomedical engineers, and all personnel associated with FPPs. Our attorneys are also sensitive to competing employee-employer interests and can facilitate a smooth working relationship. We have extensive experience vigorously defending visa applications, I-9 investigation and public access files in the event of an investigation.

Intellectual Property

We understand the myriad of complex issues that arise from the ownership of a FPP's research and development. We have experience negotiating intellectual property licensing agreements between FPPs and major academic medical centers and other third-party joint venture partners, including provisions related to joint ownership rights, IP enforcement and royalties. Our patent prosecution team's technical capability is among the most diverse within the top tier of large law firms in the United States. Our numerous Ph.D.-patent attorneys and patent agents include several postdoctoral fellows, a medical school graduate, and scientists formerly with leading biotechnology companies and research institutes. Duane Morris is ranked among the top 10 trademark filing firms by Trademark Insider and the top five busiest trademark litigation practices in 2009 by IP Law360. Our firm currently manages worldwide trademark application and registration portfolios for various companies headquartered in the United States, Asia and Europe.

Colleges and Universities

We have had the privilege of performing legal services for dozens of colleges and universities and their research affiliates. We currently have active matters for many university clients, and some of our relationships span more than 20 years. Several of the firm's attorneys have chaired and served on the boards of various academic institutions, and one partner in the firm is a member of the National Association of College and University Attorneys (NACUA).


 
 
Articles Authored by Lawyers at this office:

FDA Releases Draft Guidance on Bioequivalence Requirements for ANDA Applicants
, December 11, 2013
On December 4, 2013, the U.S. Food and Drug Administration (FDA) issued a draft guidance on demonstrating bioequivalence for drugs submitted under an Abbreviated New Drug Application (ANDA). Entitled Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA, the new...

FDA Proposed Rule Would Require Generics to Update Label Warnings Even Before Branded Pharmaceuticals Do
, November 15, 2013
On Wednesday, November 13, 2013, the U.S. Food and Drug Administration (FDA) will publish a proposed rule in the Federal Register that will mandate that generic drug firms update their labels for drugs under approved Abbreviated New Drug Applications (ANDAs) to add warnings, precautions, adverse...